Background: Emerging evidence largely based on cross sectional studies show that chronically infected HIV patients on effective combined antiretroviral therapy are susceptible to neuronal damage, which can lead to cognitive dysfunction. A low nadir CD4 has been shown to be an important predictor. This study examines the longitudinal progression of cortical atrophy in a representative cohort of HIV-positive patients on stable medication regimens. Methodology: Magnetic resonance imaging (MRI) data and relevant clinical variables were obtained from the NIH-funded HIV Neuroimaging Consortium (HIVNC) cohort, for a small subsample of 18 HIV-infected patients, across three time-points (initial scan, six-month, one-year). To extract cortical thickness values evaluations, MRI data was processed using the longitudinal stream in FreeSurfer v.5.1.1 (Martinos Institute, Boston, MA). Parametric heat maps indicating clusters of significant change were calculated and used to visualize the relationship between cortical change and key baseline clinical variables. Results: The means (SD) were: age, 48.4 (6.41) years; nadir cd4 count, 32.8 (24.62) cells/mm3; baseline cd4 levels, 319.8 (179.55) cells/mm3; duration HIV, 11.6 (7.72) years; and all on stable cART. Statistically significant (P < 0.05) regions of cortical thinning were found over time (fig 1a), which was strongly correlated with nadir CD4 concentrations (fig 1b). Cortical thinning spans a variety of brain regions corresponding to functional systems and appears to be more focused in the primary cortical rather than association regions. Conclusions: This is among the first studies to show that stably treated HIV-infected patients show progressive cortical atrophy, in part related to the nadir CD4 count. Further analysis is underway to assess the generalizability and functional relevance of these findings and determine the factors that contribute to brain tissue loss in the setting of stable and chronic disease.